We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLNT icon
651
Planet Fitness
PLNT
$4.45B
– –
-31,707
Closed -$2.14M
QSR icon
652
Restaurant Brands International
QSR
$26.2B
– –
-5,633
Closed -$437K
REG icon
653
Regency Centers
REG
$14.9B
– –
-84,285
Closed -$5.21M
RPTX
654
DELISTED
Repare Therapeutics
RPTX
– –
-50,001
Closed -$529K
SNAP icon
655
Snap
SNAP
$7.96B
$0 ﹤0.01%
13,080
-7,147
-35% -$74.7K
SOFI icon
656
SoFi Technologies
SOFI
$19.6B
– –
-13,622
Closed -$114K
STKL
657
DELISTED
SunOpta
STKL
– –
-52,189
Closed -$349K
TNDM icon
658
Tandem Diabetes Care
TNDM
$1.27B
– –
-36,587
Closed -$898K
TPR icon
659
Tapestry
TPR
$30.3B
– –
-29,480
Closed -$1.26M
VCYT icon
660
Veracyte
VCYT
$4.45B
– –
-600,926
Closed -$15.3M
VIR icon
661
Vir Biotechnology
VIR
$1.46B
$0 ﹤0.01%
11,026
-343,619
-97% -$4.9M
VRM icon
662
Vroom Inc
VRM
$36.4M
– –
-945
Closed -$109K
WOLF icon
663
Wolfspeed
WOLF
$1.04B
– –
-7,994
Closed -$444K
GTM
664
ZoomInfo Technologies
GTM
$1.03B
– –
-9,703
Closed -$246K
ZS icon
665
Zscaler
ZS
$24.9B
$0 ﹤0.01%
15,196
+1,459
+11% +$219K
ETRN
666
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-12,424
Closed -$119K
THRX
667
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-270,015
Closed -$2.52M
BKI
668
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-12,077
Closed -$721K
FORG
669
DELISTED
ForgeRock, Inc.
FORG
– –
-94,322
Closed -$1.94M
KDNY
670
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-826,155
Closed -$31.7M
ABST
671
DELISTED
Absolute Software Corp
ABST
– –
-323,044
Closed -$3.7M
ISEE
672
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-315,832
Closed -$12.4M
23 24 25 26
27

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.